BRIEF published on 01/06/2026 at 12:50, 5 days 7 hours ago Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/06/2026 at 12:45, 5 days 7 hours ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose a 0.04% interest in Avadel Pharmaceuticals plc. Details of open stock-settled derivatives positions provided Disclosure Irish Takeover Panel Stock-settled Derivatives Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 20:35, 5 days 23 hours ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Holding Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 20:30, 5 days 23 hours ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 6 days 3 hours ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 6 days 3 hours ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
BRIEF published on 11/20/2025 at 16:05, 1 month 21 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Form 8.3 Zürcher Kantonalbank Takeover Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/20/2025 at 16:00, 1 month 21 days ago Form 8.3 - Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose 0.04% interest in Avadel Pharmaceuticals plc as of 19th November 2025. No other party involved. No dealings reported Disclosure Dealings Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 11/19/2025 at 16:20, 1 month 22 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals plc Disclosure Irish Takeover Panel Zürcher Kantonalbank Securities Interests Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 16:15, 1 month 22 days ago Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.17% interest in Avadel Pharmaceuticals plc as of 18th November 2025 under Rule 8.3 of the Irish Takeover Panel Act, 1997 Irish Takeover Panel Rule 8.3 Interest Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
Published on 01/10/2026 at 05:10, 1 day 14 hours ago Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 1 day 19 hours ago Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 1 day 20 hours ago Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 1 day 20 hours ago Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction
Published on 01/10/2026 at 21:25, 22 hours 40 minutes ago CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 1 day 7 hours ago SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 1 day 22 hours ago Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 2 days 1 hour ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:19, 2 days 1 hour ago EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG
Published on 01/09/2026 at 18:30, 2 days 1 hour ago H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 2 days 2 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 2 days 2 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 2 days 23 hours ago Biannual report on SEB S.A.’S liquidity agreement
